An analysis of the cost-effectiveness of starting insulin detemir in insulin-naive people with type 2 diabetes.
AIMS: There is limited evidence with respect to the cost-effectiveness of starting insulin in people with diabetes outside the 'western' world. The aim of this study was to assess the cost-effectiveness of starting basal insulin treatment with insulin det..... Read More